Surgical Science Sweden AB (SUS) - Total Liabilities

Latest as of December 2025: Skr418.31 Million SEK ≈ $45.02 Million USD

Based on the latest financial reports, Surgical Science Sweden AB (SUS) has total liabilities worth Skr418.31 Million SEK (≈ $45.02 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Surgical Science Sweden AB - Total Liabilities Trend (2014–2025)

This chart illustrates how Surgical Science Sweden AB's total liabilities have evolved over time, based on quarterly financial data. See Surgical Science Sweden AB working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Surgical Science Sweden AB Competitors by Total Liabilities

The table below lists competitors of Surgical Science Sweden AB ranked by their total liabilities.

Company Country Total Liabilities
Wei Chih Steel Industrial Co Ltd
TW:2028
Taiwan NT$3.59 Billion
Shaniv
TA:SHAN
Israel ILA665.96 Million
Allgeier SE
XETRA:AEIN
Germany €206.34 Million
JTC Inc
KQ:950170
Korea ₩168.85 Billion
Zueblin Immobilien Holding AG
SW:ZUBN
Switzerland CHF97.33 Million
Tavia Acquisition Corp. Ordinary Shares
NASDAQ:TAVI
USA $1.78 Million
Korea Alcohol Industrial Co. Ltd
KQ:017890
Korea ₩104.52 Billion
PBA Holdings Bhd
KLSE:5041
Malaysia RM991.27 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Surgical Science Sweden AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Surgical Science Sweden AB (SUS) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.07 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Surgical Science Sweden AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Surgical Science Sweden AB (2014–2025)

The table below shows the annual total liabilities of Surgical Science Sweden AB from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 Skr418.31 Million
≈ $45.02 Million
-35.75%
2024-12-31 Skr651.03 Million
≈ $70.06 Million
+82.13%
2023-12-31 Skr357.46 Million
≈ $38.47 Million
-13.47%
2022-12-31 Skr413.11 Million
≈ $44.46 Million
+5.10%
2021-12-31 Skr393.06 Million
≈ $42.30 Million
+769.14%
2020-12-31 Skr45.22 Million
≈ $4.87 Million
-17.08%
2019-12-31 Skr54.54 Million
≈ $5.87 Million
+168.97%
2018-12-31 Skr20.28 Million
≈ $2.18 Million
+51.32%
2017-12-31 Skr13.40 Million
≈ $1.44 Million
-67.56%
2016-12-31 Skr41.30 Million
≈ $4.44 Million
+17.66%
2015-12-31 Skr35.10 Million
≈ $3.78 Million
+200.86%
2014-12-31 Skr11.67 Million
≈ $1.26 Million
--

About Surgical Science Sweden AB

ST:SUS Sweden Health Information Services
Market Cap
$169.13 Million
Skr1.57 Billion SEK
Market Cap Rank
#17292 Global
#289 in Sweden
Share Price
Skr30.80
Change (1 day)
-1.28%
52-Week Range
Skr23.92 - Skr158.30
All Time High
Skr324.75
About

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquis… Read more